Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19. NEJM. May 1st, 2020

We carried out a population-based case–control study in the Lombardy region of Italy. A total of 6272 case patients in whom infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was confirmed between February 21 and March 11, 2020. For further information click here